Moya-García, Aurelio AGonzález-Jiménez, AndrésMoreno, FernandoStephens, CamillaLucena, María IsabelRanea, Juan A G2023-05-032023-05-032022-07-21http://hdl.handle.net/10668/20981Among adverse drug reactions, drug-induced liver injury presents particular challenges because of its complexity, and the underlying mechanisms are still not completely characterized. Our knowledge of the topic is limited and based on the assumption that a drug acts on one molecular target. We have leveraged drug polypharmacology, i.e., the ability of a drug to bind multiple targets and thus perturb several biological processes, to develop a systems pharmacology platform that integrates all drug-target interactions. Our analysis sheds light on the molecular mechanisms of drugs involved in drug-induced liver injury and provides new hypotheses to study this phenomenon.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/drug-induced liver injurypolypharmacologysystems pharmacologytoxicologyChemical and Drug Induced Liver InjuryDrug-Related Side Effects and Adverse ReactionsHumansNetwork PharmacologyPolypharmacologyresearch article35886075open access10.3390/genes130712922073-4425PMC9315637https://www.mdpi.com/2073-4425/13/7/1292/pdf?version=1658480251https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315637/pdf